Infiuss Health Analysis: $125K Raised
What is Infiuss Health?
Infiuss Health builds an AI-powered Digital Patient Twin platform for clinical research and randomized controlled trial design. The company says its simulation layer supports research across cardiology, oncology, diabetes, neurology, respiratory care, maternal health, pharmacogenomics, and chronic disease. Its website claims 95% plus prediction accuracy and lists HIPAA, SOC 2 Type II, and ISO 27001 compliance claims.
Location
1 Seneca St, Buffalo, New York 14203, United States
Employees
11-50
Founded
2021
Revenue
$0-5M
Investors
- UM6P Ventures
Product Features & Capabilities
- Patient Recruitment, Patient Clinical Data, AI-powered research management platform, Effortless participant matching, Real-time compliance monitoring, Automated global clinical trial payments, Unified platform for study management
Pricing
- Free plan available
- Paid plans start at $15,000/year
- Additional features and support included in paid plans
- Academic pricing is also offered
How much Infiuss Health raised
1 - $125K
Sep 01, 2021Lead Investor: Y Combinator
Who are the founders of Infiuss Health
MB
Melissa Bime
Founder
Market Focus
Infiuss Health primarily focuses on the clinical research industry, utilizing an AI-powered ecosystem to enhance project management and accelerate research processes.
Competitors Overview
Infiuss Health operates in the clinical research market, focusing on AI-powered solutions to streamline project management and accelerate research processes. Its main competitors include:
-
Evidation Health: This company leverages AI to improve health outcomes at scale, enabling early detection of illnesses and enhancing patient monitoring. Their platform is designed to provide actionable insights from health data, which can significantly improve clinical trial outcomes.
-
myTomorrows: They utilize AI to automate the eligibility checking process for clinical trials, reducing healthcare professionals' workload by up to 90%. Their platform allows for precision trial matching, streamlining the search and referral process for physicians, which can lead to faster patient recruitment.
-
Antidote: Known for its use of AI in clinical trial marketing, Antidote employs chatbots and virtual assistants to enhance patient engagement and satisfaction. This technology helps reduce the burden on call centers and increases randomization rates in trials.
-
23andMe: While primarily known for genetic testing, 23andMe's extensive research data allows for improved drug target success rates, enhancing the likelihood of clinical success significantly. Their genetic insights can inform clinical research and development.
-
Celerion: They offer the ClinQuick® electronic data-acquisition system, which enhances data collection efficiency and ensures high-quality data across multi-site studies. This technology is crucial for maintaining consistency and accuracy in clinical research.
-
Dynacare: Although specific advantages were not detailed in the search results, Dynacare is recognized for its laboratory services and health management solutions, which may complement clinical research efforts.
These competitors differ from Infiuss Health primarily in their specific technological applications and focus areas within the clinical research ecosystem, such as patient engagement, data management, and trial matching.
See something that needs updating? Suggest edits to this profile.